085660.KQ
Chabiotech Co.,Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 6,760.00
−4.52%Year over year
Reported trailing growth
- Revenue
- +13.9%
- EBITDA
- —
- EBIT
- +5.9%
- EPS
- +107.5%
- Free cash flow
- -49.5%
- Operating cash flow
- +5.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.5%
- EBITDA
- —
- EBIT
- +4.3%
- Net income
- —
- EPS
- —
- Free cash flow
- -48.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026